Shanghai Haoyuan Chemexpress Co. Ltd. A (688131) - Total Assets
Based on the latest financial reports, Shanghai Haoyuan Chemexpress Co. Ltd. A (688131) holds total assets worth CN¥6.49 Billion CNY (≈ $949.62 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Shanghai Haoyuan Chemexpress Co. Ltd. A - Total Assets Trend (2013–2025)
This chart illustrates how Shanghai Haoyuan Chemexpress Co. Ltd. A's total assets have evolved over time, based on quarterly financial data. Also see Shanghai Haoyuan Chemexpress Co. Ltd. A (688131) market capitalisation for the company's overall valuation and market capitalisation.
Shanghai Haoyuan Chemexpress Co. Ltd. A - Asset Composition Analysis
Current Asset Composition (December 2025)
Shanghai Haoyuan Chemexpress Co. Ltd. A's total assets of CN¥6.49 Billion consist of 60.2% current assets and 39.8% non-current assets. Review Shanghai Haoyuan Chemexpress Co. Ltd. A (688131) financial obligations to assess the company's total debt and financial obligations.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 24.3% |
| Accounts Receivable | CN¥646.06 Million | 10.3% |
| Inventory | CN¥1.41 Billion | 22.3% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥154.55 Million | 2.5% |
| Goodwill | CN¥377.52 Million | 6.0% |
Asset Composition Trend (2013–2025)
This chart illustrates how Shanghai Haoyuan Chemexpress Co. Ltd. A's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Shanghai Haoyuan Chemexpress Co. Ltd. A share price for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Shanghai Haoyuan Chemexpress Co. Ltd. A's current assets represent 60.2% of total assets in 2025, a decrease from 91.4% in 2013.
- Cash Position: Cash and equivalents constituted 24.3% of total assets in 2025, up from 9.4% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 8.0% of total assets, an increase from 0.0% in 2013.
- Asset Diversification: The largest asset category is inventory at 22.3% of total assets.
Shanghai Haoyuan Chemexpress Co. Ltd. A Competitors by Total Assets
Key competitors of Shanghai Haoyuan Chemexpress Co. Ltd. A based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Torrent Pharmaceuticals Limited
NSE:TORNTPHARM
|
India | Rs443.12 Billion |
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
|
Sweden | Skr81.26 Billion |
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
|
Germany | €1.60 Trillion |
|
Beijing Tongrentang Co Ltd
SHG:600085
|
China | CN¥29.95 Billion |
|
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858
|
China | CN¥19.57 Billion |
|
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423
|
China | CN¥12.75 Billion |
|
Harbin Pharmaceutical Group Co Ltd
SHG:600664
|
China | CN¥14.08 Billion |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518
|
China | CN¥13.68 Billion |
Shanghai Haoyuan Chemexpress Co. Ltd. A - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.16 | 2.47 | 8.12 |
| Quick Ratio | 1.34 | 1.56 | 6.88 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥2.15 Billion | CN¥2.00 Billion | CN¥1.52 Billion |
Shanghai Haoyuan Chemexpress Co. Ltd. A - Advanced Valuation Insights
This section examines the relationship between Shanghai Haoyuan Chemexpress Co. Ltd. A's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.75 |
| Latest Market Cap to Assets Ratio | 0.50 |
| Asset Growth Rate (YoY) | 14.3% |
| Total Assets | CN¥6.29 Billion |
| Market Capitalization | $3.12 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Shanghai Haoyuan Chemexpress Co. Ltd. A's assets below their book value (0.50x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Shanghai Haoyuan Chemexpress Co. Ltd. A's assets grew by 14.3% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Shanghai Haoyuan Chemexpress Co. Ltd. A (2013–2025)
The table below shows the annual total assets of Shanghai Haoyuan Chemexpress Co. Ltd. A from 2013 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥6.29 Billion ≈ $921.05 Million |
+14.34% |
| 2024-12-31 | CN¥5.50 Billion ≈ $805.55 Million |
+31.31% |
| 2023-12-31 | CN¥4.19 Billion ≈ $613.45 Million |
+16.52% |
| 2022-12-31 | CN¥3.60 Billion ≈ $526.46 Million |
+50.88% |
| 2021-12-31 | CN¥2.38 Billion ≈ $348.93 Million |
+178.29% |
| 2020-12-31 | CN¥856.84 Million ≈ $125.38 Million |
+57.95% |
| 2019-12-31 | CN¥542.49 Million ≈ $79.38 Million |
+78.17% |
| 2018-12-31 | CN¥304.48 Million ≈ $44.55 Million |
+58.85% |
| 2017-12-31 | CN¥191.68 Million ≈ $28.05 Million |
+22.72% |
| 2016-12-31 | CN¥156.19 Million ≈ $22.86 Million |
+109.78% |
| 2015-12-31 | CN¥74.46 Million ≈ $10.90 Million |
+29.75% |
| 2014-12-31 | CN¥57.39 Million ≈ $8.40 Million |
+66.38% |
| 2013-12-31 | CN¥34.49 Million ≈ $5.05 Million |
-- |
About Shanghai Haoyuan Chemexpress Co. Ltd. A
Shanghai Haoyuan Chemexpress Co., Ltd. researches, develops, and manufactures pharmaceutical intermediates and small molecule drugs. The company offers APIs and API intermediates, vitamin D series compounds, CRO building blocks, and CRO life bioscience compounds. The company was founded in 2006 and is headquartered in Shanghai, China.